Shelter Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE013V01011
  • NSEID:
  • BSEID: 543963
INR
45.54
0.95 (2.13%)
BSENSE

Nov 20

BSE+NSE Vol: 27000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10038980,
    "name": "Shelter Pharma",
    "stock_name": "Shelter Pharma",
    "full_name": "Shelter Pharma Ltd",
    "name_url": "stocks-analysis/shelter-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "45.54",
    "chg": 0.95,
    "chgp": "2.13%",
    "dir": 1,
    "prev_price": "44.59",
    "mcapval": "78.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543963,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE013V01011",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": 27000,
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/shelter-pharma-10038980-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 2,
    "sid": "10038980",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/shelter-pharma-10038980"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Un-Audited Standalone Financial Results For The Half Year Ended September 30 2026",
      "datetime": "07-Nov-2026",
      "details": "With reference to the subject matter and pursuant to the Regulation 30 32 & 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (\"SEBI LODR\") we would like to inform you that the Board of Directors of the Company at its meeting held today i.e Saturday 07th November 2026 at corporate office of the company at 5TH Floor 501 SAKAR 4 Opp. Town Hall Ashram Road Ahmedabad Gujarat -380006 has considered and approved the following:",
      "source": "BSE"
    },
    {
      "caption": "Submission Of The Un-Audited Standalone Financial Results For The Half Year Ended September 30 2026",
      "datetime": "07-Nov-2026",
      "details": "Attached herewith Financial Results for Half year ended 30th September 2026",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "07-Nov-2026",
      "details": "Attached herewith Statement of Deviation for quarter ended 30th September 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shelter Pharma Ltd has declared <strong>3%</strong> dividend, ex-date: 23 Sep 25",
          "dt": "2025-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Un-Audited Standalone Financial Results For The Half Year Ended September 30 2026

07-Nov-2026 | Source : BSE

With reference to the subject matter and pursuant to the Regulation 30 32 & 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI LODR") we would like to inform you that the Board of Directors of the Company at its meeting held today i.e Saturday 07th November 2026 at corporate office of the company at 5TH Floor 501 SAKAR 4 Opp. Town Hall Ashram Road Ahmedabad Gujarat -380006 has considered and approved the following:

Submission Of The Un-Audited Standalone Financial Results For The Half Year Ended September 30 2026

07-Nov-2026 | Source : BSE

Attached herewith Financial Results for Half year ended 30th September 2026

Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

07-Nov-2026 | Source : BSE

Attached herewith Statement of Deviation for quarter ended 30th September 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Shelter Pharma Ltd has declared 3% dividend, ex-date: 23 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available